A medical device is disclosed for monitoring and modulating uterine contractions. The medical device may include a uterine pacemaker and an intravaginal electrode carrier, which may both be located within the body. The intravaginal electrode carrier includes sensing and modulating electrodes that measure uterine electroactivity and apply electrical modulation, respectively. The uterine pacemaker receives the measured uterine electroactivity from the intravaginal electrode carrier and generates the electrical modulation applied by the modulating electrodes. The electrical modulation may be used to inhibit or induce uterine contractions. The intravaginal electrode carrier may be used in addition or as an alternative to an external uterine muscle activity monitor (e.g., a tocodynamometer) for a more accurate measure of uterine contractions that is noninvasive.

The present invention relates to a device for the prevention and/or treatment of fecal and/or urinary incontinence. The device may fit into a vagina. The device may include a pressure sensor and electrodes. The device may include a lateral projection on the device and/or a skin of the device. In response to intra-abdominal pressure the device may apply electrostimulation with the electrodes, for example to a vaginal mucosa.

A device for muscle training and treating urinary incontinence including a body configured for insertion intravaginally for placement within the vagina, at least one sensor supported on the body for measuring intra-abdominal pressure and at least one electrode supported on the body and in electrical communication with the at least one sensor. The at least one electrode sends an electrical signal to pelvic muscles of a user to contract the pelvic muscles based on feedback from the sensor. An electric signal generator housed within the body sends the electrical signal to the electrode. The device can also have application for treating fecal incontinence and pelvic floor weakness.

Devices for treating postpartum hemorrhaging.

A method for a genital tissue treatment comprises providing a device including a central control unit, an energy generator and an internal applicator, wherein the internal applicator is detachable and includes at least one ring-shaped circular energy delivery element encircling or around the internal applicator, with the at least one circular energy delivery element, inserting the internal applicator into vagina and into or onto the genital tissue, transferring radiofrequency energy into the genital tissue, heating the genital tissue and, wherein the applicator includes at least one temperature sensor in communication with the central control unit or the energy generator and providing a feedback during treatment, wherein the feedback includes changing output of at least one energy delivery element.

A transvaginal stimulation device incorporates various securing mechanisms configured to maintain secure engagement between the treatment portion of a transvaginal stimulation device and target tissue to increase the efficacy of therapeutic stimulation treatment. The device includes a concave portion configured with a stimulation array of electrodes, and the securing mechanism maximizes engagement between the stimulation array and the tissue to be treated. The device includes a flexible mechanism that increases the ability of the device to conform to the vaginal canal to maximize electrode contact. The securing mechanisms may be manually controlled or automatically controlled using predictive models trained using patient data. The predictive models may include machine learning models trained to dynamically modify device position and/or therapy in response to receipt of real-time information.

An intravaginal electrical stimulation device for treating pelvic pain in a female patient includes, in one embodiment, a set of intravaginal components comprising a frame, at least one pair of paracervical electrodes, an intravaginal capsule, a socket in the proximal end of the intravaginal capsule, an electrode plug that plugs into the socket, and connecting wires that electrically couple the electrode plug to the paracervical electrodes. The intravaginal components are designed to inserted into the patient's vagina so that one or more electrodes are in direct contact with the vaginal epithelium in the lateral vaginal fornices. In some embodiments, a cutaneous electrode may be included to be attached to the skin of the female patient. A microprocessor and an electrical stimulation generator are operable to cause low-voltage electrical current to flow through the intravaginal electrodes, the cutaneous electrode, or both, to create one or more electrical fields that neuromodulate the intrapelvic nerves of the patient. An external controller, which communicates with the intravaginal components over a wireless data communications channel, sends instructions to and receives status updates from the microprocessor inside the intravaginal capsule. In some embodiments, the electrical stimulation generator is located inside an external electrical stimulator generator (EESG) worn outside the body, instead of being located in an intravaginally worn intravaginal capsule, and the EESG is electrically coupled to the intravaginal components via one or more connecting wires that pass through the orifice of the female patient's vagina.